BELLICUM PHARMACEUTICALS INC (BLCM)
US0794814048 - Common Stock
BELLICUM PHARMACEUTICALS INC
NASDAQ:BLCM (6/1/2023, 7:00:02 PM)
After market: 0.6288 +0.01 (+1.09%)0.622
-0.07 (-9.72%)
Company Profile
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2014-12-18. The firm is focused on discovering and developing novel, controllable cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors. Its Chemical Induction of Dimerization (CID), technology platform is designed to enable control of components of the immune system in real time. CID consists of molecular switches, modified forms of these signaling proteins, which are triggered inside the patient by infusion of a small molecule, instead of by natural upstream signals. The company has developed two such switches: an activation switch, designed to stimulate activation, proliferation and persistence of the immunotherapy cells and provide other immunomodulatory benefits, and a safety switch, designed to initiate programmed cell death, or apoptosis, of the immunotherapy cell.
Company Info
BELLICUM PHARMACEUTICALS INC
3730 Kirby Drive, Suite 1200
Houston TEXAS 77098
P: 18323841100.0
CEO: Richard A. Fair
Employees: 13
Website: https://www.bellicum.com/
BLCM News
2 months ago - Seeking AlphaBellicum sells assets to MD Anderson, moves towards liquidation (OTCMKTS:BLCM)Bellicum Pharmaceuticals (BLCM) has completed the sale of substantially all of its assets to the MD Anderson Cancer Center and will proceed with liquidation. Read more here.
a year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday!
a year ago - InvestorPlaceWhy Is Tupperware Brands (TUP) Stock Down 8% Today?Tupperware Brands (TUP) stock is taking a beating on Monday after the company said it's exploring strategic alternatives.
a year ago - InvestorPlaceWhy Is Aptorum (APM) Stock Down 16% Today?Aptorum (APM) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq.
BLCM Twits
Here you can normally see the latest stock twits on BLCM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
